W2B-43267-29997
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 749 / OK
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-11
- 2021-01-13
- 2021-01-14
- 2021-01-21
-
2021-01-28
Survey response — day 21, dose 2MedDRA: Diarrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Diary two separate daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — day 28, dose 2MedDRA: Abnormal faeces, Chills — Feeling: FairFree text: Unusual stools, chills (higher than normal temperature for myself)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
-
2021-04-08
Survey response — 3 months, dose 2MedDRA: Nausea — Feeling: Fair · Be unable to work or attend schoolFree text: NauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-08
-
2022-01-07
Survey response — 12 months, dose 2MedDRA: Infection, Respiratory failure — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Vivid infection August 11,2021 with residual respiratory failure. Now resolvedMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-07 | Unsuccessful |
Free text
Release 2 — day 21, dose 2
Symptoms: Diary two separate days
Release 3 — day 28, dose 2
Symptoms: Unusual stools, chills (higher than normal temperature for myself)
Release 7 — 3 months, dose 2
Symptoms: Nausea
Release 10 — 12 months, dose 2
Symptoms: Vivid infection August 11,2021 with residual respiratory failure. Now resolved
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal faeces | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Infection | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Respiratory failure | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release